Venus Medtech (Hangzhou) Inc Class H VMTHF
Trading Information
- Previous Close Price
- $0.27
- Day Range
- $0.42–0.42
- 52-Week Range
- $0.25–0.52
- Bid/Ask
- $0.10 / $0.18
- Shares Outstanding
- 441.01M
- Market Cap
- $186.06M
- Volume/Avg
- 1,026 / 1,026
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.33
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Venus Medtech (Hangzhou) Inc is engaged in the medical devices that integrate R&D, clinical development, manufacturing, and commercialization. The company has developed a product portfolio covering the interventional devices for valvular heart diseases, including transcatheter aortic valve replacement (TAVR), transcatheter pulmonary valve replacement (TPVR), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve replacement (TTVR), and other procedural accessories, allowing it to provide overall solutions for physicians and patients. Geographically, the company operates in mainland China, Israel, Hong Kong, the USA, and the Netherlands. The majority of the revenue is derived from Mainland China.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 560
- Website
- https://www.venusmedtech.com
Valuation
|
Metric
|
VMTHF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.74 |
Price/Sales | 4.33 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
VMTHF
|
|---|---|
Quick Ratio | 2.24 |
Current Ratio | 2.77 |
Interest Coverage | −22.01 |
Quick Ratio
VMTHF
Profitability
|
Metric
|
VMTHF
|
|---|---|
Return on Assets (Normalized) | −12.72% |
Return on Equity (Normalized) | −18.72% |
Return on Invested Capital (Normalized) | −15.82% |
Return on Assets
VMTHF
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|>phn@& | LOCK|zVQz | $190B | |||
| Stryker Corp
SYK
| LOCK|MbQw@FxP | LOCK|B$ | $134B | |||
| Medtronic PLC
MDT
| LOCK|?<k>ZY | LOCK|mw$> | $116B | |||
| Boston Scientific Corp
BSX
| LOCK|>LWw$L^ | LOCK|W%<& | $74B | |||
| Edwards Lifesciences Corp
EW
| LOCK|%hwl#L^q | LOCK|^#%! | $54B | |||
| DexCom Inc
DXCM
| LOCK|GC$f&m> | LOCK|>&p< | $34B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|kf^>D$R | LOCK|q$ | $33B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|D$ | LOCK|T<@ | $27B | |||
| Steris PLC
STE
| LOCK|q?KQk< | LOCK|z&>% | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|PtZ@hFt | LOCK|#R | $19B |
United States